The tariff classification of blood glucose monitoring systems from various countries
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated June 27, 2025, on behalf of your client, Arkray Factory USA, Inc., you requested a tariff classification ruling. Descriptive literature was provided for our review. The first item under consideration is the Assure Platinum Meter (part number 500001), which is a blood glucose monitoring system designed for use in long-term care and multi-patient settings. It works by using a small blood sample (0.5 microliter) applied to a test strip inserted into the meter.
The meter then analyzes the blood sample and displays the glucose reading within 7 seconds. The meter measures the electrical current produced by the enzymatic reaction between the glucose in the blood sample and the reagent on the test strip. The meter features a backlit LCD display, a test strip ejector, and stores up to 500 test results with time and date stamps. The system includes the meter and owner’s guide and is produced in the Philippines.
The second item under consideration is the Assure Prism Multi Meter (part number 530001), which is a blood glucose monitoring system designed for use in professional healthcare settings. It allows healthcare professionals to quantitatively measure glucose levels in fresh capillary whole blood samples, providing fast and accurate results. The meter operates substantially similar to the first item by analyzing a small blood sample applied to a test strip, with results displayed on the meter’s screen within seconds.
The system includes the meter and owner’s guide and is produced in South Korea. The third item under consideration is the Glucocard Vital Meter Basic (part number 760001), which is a blood glucose monitoring system that measures the amount of glucose in a blood sample taken from a fingertip or palm. It uses auto-coding technology, meaning it automatically calibrates when a test strip is inserted, simplifying the testing process.
The meter then detects the glucose level in the blood sample and displays the result on a large, easy-to-read screen. The system includes the meter and owner’s guide and is produced in the Philippines. The fourth item under consideration is the Glucocard Shine Meter Basic (part number 540001), which is a blood glucose monitoring system that measures blood glucose levels by analyzing the electrical current generated when a blood sample reacts with a chemical on the test strip.
This electrical current is then converted into a glucose reading displayed on the meter. The system includes the meter, carrying case, and owner’s guide and is produced in South Korea. The fifth item under consideration is the Glucocard Expression Meter Basic (part number 570001), which is a blood glucose monitoring system that works by analyzing a small blood sample applied to a test strip. The meter uses a chemical reaction within the strip to determine the blood glucose level.
After the sample is applied, the meter counts down and then displays the glucose reading on its screen. The meter also has optional voice features to assist users with setup and testing. The system includes the meter, carrying case, and owner’s guide, and is produced in Taiwan.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N350731).